Literature DB >> 35178676

Cycle threshold responses in SARS-COV2 PCR tests depend on the method by which the samples were obtained and require strict global standardization.

Shimon Edelstein1, Miriam Sudri2, Shibli Tanous2, Hila Ben Amram3, Adi Sharabi-Nov4, Inna Rozenfeld5, Hedva Halal5, Salman Zarka6.   

Abstract

PURPOSE: Since 2020, a SARS-COV2 epidemic has been raging worldwide. The cycle of the PCR test in which the virus is detected is called cycle threshold (CT). The method of obtaining the sample is not detailed in any published study and is based on general guidelines of the CDC. Our contention is that the manner in which the sample is obtained has a dramatic effect on CT values.
METHODS: For each person suspected of having Covid-19 who arrives at the emergency room, two swabs are taken in succession, one according to CDC guidelines and the other according to "Ziv" guidelines. The Ziv method sample collection guidelines determine the depth of penetration, the number of rotations of the swab, and their direction. Each double sample was sent for analysis.
RESULTS: Analysis of the CT results of the sample to results methods and of the Seegene platform clearly found (p = 0.003 and p = 0.001, respectively) that more rigorous sample collection yielded lower CT values.
CONCLUSION: The method of obtaining the samples had a dramatic effect on CT results. Any publication that includes CT results, and certainly studies that discuss CT kinetics, must describe in detail the method by which the samples were obtained. In places where it is also important to detect the onset of illness (airports, hospitals, schools, etc.), it is important to use the Ziv method to reduce the risk of false negatives.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cycle threshold; PCR; Sars-COV2; Viral load

Mesh:

Substances:

Year:  2022        PMID: 35178676      PMCID: PMC8853610          DOI: 10.1007/s15010-022-01772-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  9 in total

1.  Cycle Threshold to Test Positivity in COVID-19 for Return to Work Clearance in Health Care Workers.

Authors:  Sandra Domeracki; Robert N Clapp; Kristopher Taylor; Chuanyi M Lu; Harry Lampiris; Paul D Blanc
Journal:  J Occup Environ Med       Date:  2020-11       Impact factor: 2.162

2.  Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.

Authors:  Jared Bullard; Kerry Dust; Duane Funk; James E Strong; David Alexander; Lauren Garnett; Carl Boodman; Alexander Bello; Adam Hedley; Zachary Schiffman; Kaylie Doan; Nathalie Bastien; Yan Li; Paul G Van Caeseele; Guillaume Poliquin
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

Review 3.  A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19.

Authors:  Sonia N Rao; Davide Manissero; Victoria R Steele; Josep Pareja
Journal:  Infect Dis Ther       Date:  2020-07-28

4.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.

Authors:  Bernard La Scola; Marion Le Bideau; Julien Andreani; Van Thuan Hoang; Clio Grimaldier; Philippe Colson; Philippe Gautret; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-27       Impact factor: 3.267

5.  Development of a real-time reverse-transcription-PCR method for detection of RD114 virus in canine vaccines.

Authors:  Rie Narushima; Tomoaki Shimazaki; Toshio Takahashi
Journal:  Biologicals       Date:  2011-02-22       Impact factor: 1.856

Review 6.  Current methods and prospects of coronavirus detection.

Authors:  Jiaqi Bu; Zhiwei Deng; Hui Liu; Jiacheng Li; Yanjing Yang; Shian Zhong
Journal:  Talanta       Date:  2020-12-31       Impact factor: 6.556

7.  Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?

Authors:  Nobuhiro Asai; Daisuke Sakanashi; Wataru Ohashi; Akiko Nakamura; Atsuko Yamada; Yuzuka Kawamoto; Narimi Miyazaki; Tomoko Ohno; Isao Koita; Hiroyuki Suematsu; Takaaki Kishino; Hideo Kato; Mao Hagihara; Arufumi Shiota; Yusuke Koizumi; Yuka Yamagishi; Hiroshige Mikamo
Journal:  J Infect Chemother       Date:  2020-09-09       Impact factor: 2.211

Review 8.  Recent advances and perspectives of nucleic acid detection for coronavirus.

Authors:  Minzhe Shen; Ying Zhou; Jiawei Ye; Abdu Ahmed Abdullah Al-Maskri; Yu Kang; Su Zeng; Sheng Cai
Journal:  J Pharm Anal       Date:  2020-03-01

9.  The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.

Authors:  Carlos Chaccour; Paula Ruiz-Castillo; Mary-Ann Richardson; Gemma Moncunill; Aina Casellas; Francisco Carmona-Torre; Miriam Giráldez; Juana Schwartz Mota; José Ramón Yuste; José Ramón Azanza; Miriam Fernández; Gabriel Reina; Carlota Dobaño; Joe Brew; Belen Sadaba; Felix Hammann; Regina Rabinovich
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.